Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Briassoulis

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Chemotherapy (Florence, Italy)|December 1, 1994
Is the combination of 5-fluorouracil and folinic acid effective in advanced gastric carcinoma? Results of a pilot study and review of the literatureN Pavlidis, C Nicolaides, G Klouvas, et al.
Anticancer Research|November 1, 1995
Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary originN Pavlidis, E Briassoulis, M Bai, et al.
Cancer|June 15, 1992
Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patientsN A Pavlidis, C Petris, E Briassoulis, et al.
Anticancer Research|January 19, 1999
p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up studyD G Stefanou, A V Nonni, N J Agnantis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology GroupP A Kosmidis, N Tsavaris, D Skarlos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group StudyN Pavlidis, P Kosmidis, D Skarlos, et al.
Haematologica|May 1, 1994
Second malignancies following treatment for Hodgkin's disease: a Greek experienceT Economopoulos, N Stathakis, C Alexopoulos, et al.
Seminars in Oncology|January 14, 1998
Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancerG Fountzilas, A Athanassiades, A Kalogera-Fountzila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology GroupD Bafaloukos, H Gogas, V Georgoulias, et al.
Medical and Pediatric Oncology|January 1, 1994
Evaluation of six tumor markers in patients with carcinoma of unknown primaryN Pavlidis, J Kalef-Ezra, E Briassoulis, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Chemotherapy (Florence, Italy)|December 1, 1994
Is the combination of 5-fluorouracil and folinic acid effective in advanced gastric carcinoma? Results of a pilot study and review of the literatureN Pavlidis, C Nicolaides, G Klouvas, et al.
Anticancer Research|November 1, 1995
Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary originN Pavlidis, E Briassoulis, M Bai, et al.
Cancer|June 15, 1992
Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patientsN A Pavlidis, C Petris, E Briassoulis, et al.
Anticancer Research|January 19, 1999
p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up studyD G Stefanou, A V Nonni, N J Agnantis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology GroupP A Kosmidis, N Tsavaris, D Skarlos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group StudyN Pavlidis, P Kosmidis, D Skarlos, et al.
Haematologica|May 1, 1994
Second malignancies following treatment for Hodgkin's disease: a Greek experienceT Economopoulos, N Stathakis, C Alexopoulos, et al.
Seminars in Oncology|January 14, 1998
Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancerG Fountzilas, A Athanassiades, A Kalogera-Fountzila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology GroupD Bafaloukos, H Gogas, V Georgoulias, et al.
Medical and Pediatric Oncology|January 1, 1994
Evaluation of six tumor markers in patients with carcinoma of unknown primaryN Pavlidis, J Kalef-Ezra, E Briassoulis, et al.
Pageof 2